Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Unite de Fabrication de Medicaments SA

UMED.TN ✓ COMPLIANT ☆ Track — members

Bourse de Tunis · Healthcare · Pharmaceuticals ·

Tunisia Micro Cap Analyst: SELL

Last Close

$3.54

▼ -0.78%

Market Cap $113.13M · Vol 34.77K

Key Metrics

P/E Ratio

19.39

FWD: 18.19

Market Cap

$113.13M

Micro Cap

Div Yield

6.13%

Annual dividend

EPS Growth

+1.24%

YoY

RSI (14)

46.03

Momentum

Beta

0.31

vs Market

52W High

$3.81

5.47% below

52W Low

$2.74

32.21% above

Volume

34.77K

Avg 26.48K

P/B

2.72

Price-to-book

ROE

N/A

Return on equity

Free Float

29.98%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Unite de Fabrication de Medicaments SA (UMED.TN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does UMED.TN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.78%

-2.39%

+10.03%

+10.87%

YTD

+7.94%

+13.33%

+42.95%

+45.71%

Financials & Valuation

TTM · Annual

Total Revenue	$51.93M
Net Income	$5.87M
Revenue Growth (YoY)	-5.59%
Gross Margin	53.21%
Operating Margin	21.29%
Net Profit Margin	11.31%
ROE	N/A
ROA · ROIC	12.86% · 12.78%

P/E Ratio	19.39
Forward P/E (FY1)	18.19
PEG Ratio	-2.04
P/S	2.03
P/B	2.72
P/FCF	18.89
EPS Growth	+1.24%
Outstanding Shares	32.00M

Technical Indicators

50-Day SMA	$3.56
200-Day SMA	$3.24
RSI (14)	46.03
Beta	0.31
52-Week High	$3.81
52-Week Low	$2.74

Volume Today	34.77K
Avg Daily Volume (30D)	26.48K
Relative Volume	1.31x
Volatility (10D)	22.02
Volatility (30D)	29.15
Free Float	29.98%

Analyst Consensus

SELL

Current Price $3.54

Mean Target N/A

52W Low$2.74 52W High$3.81

Current

Target

$2.74 $3.81

Current Analyst target

· 1 analysts

Identifiers

ExchangeBourse de Tunis

FIGIBBG004GWSFN4

ISINTN0007720014

CountryTunisia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co +0.88% JNJ Johnson & Johnson +1.07% ABBV Abbvie Inc +1.20% NVS Novartis AG +1.68% NOVN.S Novartis AG +0.85%

Company Profile

Unite de Fabrication de Medicaments SA is a Tunisia-based company principally engaged in the pharmaceutical sector. The Company has labaroatories where it develops production in two main areas: Generic Drugs, where it concentrates on the production and marketing of drugs under its own brand of Unimed, and Shaped Drugs, which are the drugs manufactured for third party laboratories customers. The Company's product portfolio comprises Ophthalmology Otorhinolaryngologicals (OPHTA ORL) like Alzor, Atropine Unimed and Benzosept, among others; liquid injections, such as Bupicaine, Furoxem, Doperan and Ketomed, among others; powders for injections, such as Amoxil, Ampicil and Cefaxone, among others; Otorhinolaryngologicals (ORL) like Ofloxacine; and infusion solutions, such as Glucose 5% and Osmomed 5%, among others.